Atlas Trials

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

Clinical trial NCT02735603 · COMPLETED

Trial details

NCT number
NCT02735603
Sponsor
Orexigen Therapeutics, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Repolarization
Start date
2016-04-01
Primary completion
2016-07-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.